Sattva S. Neelapu MD, from MD Anderson Cancer Center discusses beyond ZUMA-1 and evaluating Axi-Cel efficacy at the 2017 American Society of Hematology.
Beyond ZUMA-1 Evaluating Axi-Cel efficacy
Sattva S. Neelapu MD, from MD Anderson Cancer Center discusses beyond ZUMA-1 and evaluating Axi-Cel efficacy at the 2017 American Society of Hematology.